Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Announces Positive Profit Alert 2018-03-05 17:48
WuXi Biologics Congratulates MabSpace on FDA Clearance of IND for MSB2311 2018-02-27 08:04
WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development 2018-02-09 09:04
WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC 2018-01-31 07:52
WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500 2018-01-30 09:00
WuXi Biologics Announces Formation of Scientific Advisory Board 2018-01-24 17:05
WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer 2018-01-15 08:10
WuXi Biologics and Phanes Sign MOU and Announce Strategic Development and Manufacturing Partnership 2017-12-14 17:20
WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors 2017-12-06 16:23
WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory 2017-11-03 10:30
WuXi Biologics Announces 2017 Interim Results 2017-08-22 14:03
WuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus Biosciences 2017-08-17 19:22
WuXi Biologics is Officially Listed on the Hong Kong Stock Exchange 2017-06-13 09:55
1 5 6 7 8 9